MDx-Chex™ for BCID2

MDx-Chex for BCID2 is a first-of-its-kind quality control designed to meet the standards for verifying the performance of the BIOFIRE® Blood Culture Identification 2 (BCID2) Panel for sepsis. Provided in a comprehensive and easy-to-use format, MDx-Chex for BCID2 evaluates the entire analytical process of the assay, including cell lysis, DNA extraction, purification and removal of PCR inhibitors, as well as qPCR amplification, detection and analysis. MDx-Chex for BCID2 can be used for assay verification, to track lot-to-lot performance of the BCID2 assay and to reduce the occurrence of incorrect results due to instrument or assay failures.

MDx-Chex for BCID2 is a patient-like full process control designed to validate the entire analytical process of the BIOFIRE BCID2 Panel. The control kit contains 43 bacteria, yeasts and antimicrobial resistance gene targets packaged in two separate vials, one for Gram (-) bacteria and one for the Gram (+) bacteria and yeasts, covering targets tested on the BIOFIRE BCID2 Panel. The microorganisms are intact, inactivated and suspended in a matrix of stabilized red blood cells, white blood cells and blood culture media components, which is designed to challenge the lysis and purification processes just like a patient sample.

Show More
Using MDx-Chex for BCID2

For In Vitro Diagnostics Use.

A step-by-step instruction for using MDx-Chex for BCID2 with the BIOFIRE FilmArray® 2.0 and Torch Systems.


  • Comprised of inactivated microorganisms in a matrix of blood cells and culture media components to simulate a patient sample.
  • Two BIOFIRE BCID2 pouches needed for complete coverage of all 43 targets,  which are contained in two vials.
  • Allows for direct use on the BIOFIRE FilmArray Torch and 2.0 platforms.


  • Challenges and verifies the entire analytical process of the BIOFIRE BCID2 Panel assay.
    • Cell lysis
    • DNA extraction/purification
    • PCR inhibition
    • Detection analysis
    • Results reporting
  • Saves the use of expensive BIOFIRE BCID2 Panel pouches.
    • Use 2 pouches vs. 6 pouches, as needed with some competitor controls.
    • Provides complete target coverage.
  • Easy to use.
    • Pipette like a patient sample from a blood culture bottle.
    • No pooling of individual microorganisms needed.
  • Reduces preanalytical variables.
    • Pipetting errors
    • Cross-contamination

DescriptionCatalog Number
1 Gram (–) bacteria and 1 Gram (+) bacteria vial, 5 run capacity250065

Order MDx-Chex for BCID2 today

New customers

Existing customers

International customers find a distributor

Streck’s antibiotic resistance monitoring and detection (ARM-D) kits can be used as a part of a hospital’s surveillance program when screening patients and by identifying – in just a few hours – which Gram-negative resistant bacterial strains are present in the facility. Streck’s real-time PCR instrument and hot-start enzyme formulated for fast PCR can save your lab time without compromising results.

Streck ARM-D Kits

The latest from the blog


A link between AMR and COVID-19

Several recent publications and communications from infectious disease experts have illustrated what has been called the hidden threat behind COVID-19…
Read More

Antimicrobial resistance in pets

Antimicrobial resistance (AMR) has become a significant public health issue globally, including in the United States. The issue is a worsening problem…
Read More

AMR in the food chain

The food supply chain in the United States is among the safest in the world, but keeping it safe has become more challenging due to the rapidly evolvi…
Read More